LGM Pharma supplies active pharmaceutical ingredients today, for tomorrow’s innovative drug therapies, to supply research teams with chemotherapy drugs for mesothelioma, and to aid in the fight to cure cancer. Making a positive difference is our main goal.
The most commonly used combination of chemotherapy drugs for mesothelioma is pemetrexed and cisplatin. Sometimes pemetrexed is combined with carboplatin. Other combinations or individual drugs may be used, including the following APIs (Active Pharmaceutical Ingredients) supplied by LGM Pharma for research and development purposes:
For peritoneal chemotherapy into a vein, cisplatin and pemetrexed is the most common combination but one or more of the following drugs may be used
*Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk.